Skip to main navigation Skip to search Skip to main content

Thalidomide inhibits granulocyte responses in healthy humans after ex vivo stimulation with bacterial antigens

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Ingestion of thalidomide was associated with a reduction in the upregulation of the granulocyte activation marker CD11b and a reduced capacity to release elastase and lactoferrin after stimulation with lipopolysaccharide or lipoteichoic acid. A single oral dose of thalidomide attenuates neutrophil activation upon ex vivo stimulation with bacterial antigens
Original languageEnglish
Pages (from-to)1547-1549
JournalAntimicrobial agents and chemotherapy
Volume45
Issue number5
DOIs
Publication statusPublished - 2001

Fingerprint

Dive into the research topics of 'Thalidomide inhibits granulocyte responses in healthy humans after ex vivo stimulation with bacterial antigens'. Together they form a unique fingerprint.

Cite this